Home
The Department of Biomedicine

News archive for The Department of Biomedicine

New findings provide a better understanding of how the synthesis of dopamine is regulated in the brain. It may shed new light on the mechanism behind diseases such as Parkinson's.
In June 2022, Bergen will host an EMBO Workshop focusing on biological regulation via proteins, more specifically protein ends. This emerging scientific theme will gather scientists from all over the world including more than 30 invited speakers.
On a rare occasion, almost the whole IK group got together in Oulu, so we of course took the chance to have a photo shoot! What a lovely bunch of people we are!
Malaria is one of the most devastating infectious diseases in the world. The parasites causing malaria move by gliding, for which force is generated by an unusual actomyosin motor. We have determined a high-resolution crystal structure of one of the key regulators of parasite actin dynamics, the homodimeric actin capping protein alpha.
On September 17th, we celebrated our first PhD from the UiB, Dr. Andrea Johana Lopez Moreno.
The University of Bergen and NTNU have joined forces to establish a new research-centre on the brain. On Wednesday October 13th, the centre will officially open in Bergen.
Our research project BIOPROM (Biomimetic Proteolipid Multilayers - Structure and Properties) was awarded a research grant of 12 MNOK by the Research Council of Norway. The BIOPROM project will reveal unprecedented details of the molecular structure and properties of myelin, from the nano to the meso scale.
The Norwegian Cancer Society announced September 2nd that this year’s King Olav V's Prize for Cancer Research will go to Professor Bjørn Tore Gjertsen. The award amounts to 1 million NOK, is considered as a great honor in the Norwegian research communities and goes to the very best in the entire spectrum of Norwegian cancer research.
Professor Karl Johan Tronstad at the University of Bergen has supervised a study which found biochemical changes in the blood of ME patients. The results support the hypothesis that the disease involves impaired cellular energy metabolism.
Prof. Meg Veruki of the Retinal Microcircuits research group has been selected to the "Top List" of Excellent Women in European Vision Research and Ophthalmology 2021
Fundamentally new discoveries in biology or medicine are rare. The mentioned article is an example of such a discovery. The findings of this study will probably soon be found in standard textbooks in biochemistry and physiology.
Read about druggabily predictions for RNA targets, the current state of fragment-based drug discovery for RNA, and an experimental toolbox to push drug discovery for antibiotics.
Variants in different genes may cause developmental delay and various syndromes. Researchers from USA, Saudi Arabia and Norway recently uncovered pathogenic gene variants causing developmental delay and intellectual disabilities in a gene not previously linked to genetic disease.
Vipul has presented an update of our JPIAMR EXPLOR project on a recent JPIAMR workshop (25:55 to 38:02)
An Experimental Toolbox for Structure-Based Hit Discovery for P. Aeruginosa FabF, a Promising Target for Antibiotics
A new study from the University in Bergen may shed light on the comorbidities found in adults suffering from this rare disease.

Pages